Moderna (MRNA) stock drops even after beating Q2 2025 forecasts, as it lowered the top end of the revenue outlook due to ...

Moderna surpassed Wall Street sales predictions due to strong Spring COVID booster demand but lowered its 2025 sales forecast, causing a premarket share decline. Despite a 41% revenue drop to $142 ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

Question: Thank goodness that tsunami was not a big deal after all. Would homeowner’s insurance even cover that?

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...

Despite the irresponsible “political” noise surrounding the matter, vaccines remain an important step for parents to take in keeping their children as healthy and safe as possible. For those with ...

It’s time to get back to the classroom - but for students who suffer from asthma, a new school year can be challenging in ...

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

It’s the last day of July, which means the school year is almost here and returning to the classroom can often mean exposure to germs, which can be especially hard for the millions of children in the ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals.

Merck (MRK) may be a storied pharmaceutical giant with a 134-year history, but it still has a lot of room to run. Merck is ...

Diary Queen's annual Miracle Treat Day is July 31st, where a dollar from every Blizzard purchased goes to the Children's ...